← Back to Search

Procedure

TMS for Epilepsy

N/A
Waitlist Available
Led By Anli Liu, MD, MA
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
12-60 years of age
Planned neurosurgery involving implantation subdural electrodes over the precentral gyrus
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights

Study Summary

This trial will help determine whether nTMS is a reliable method for identifying the hand motor cortex in adults with epilepsy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You must be between 12 and 60 years old.
Select...
You are scheduled to have a surgery that involves placing electrodes on a specific part of your brain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average Distance Between Positive Motor Functional Sites of fMRI
Average Distance Between Positive Motor Functional Sites of nTMS
Average Distance Between Positive Motor Mapping Sites of DCS
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: nTMSExperimental Treatment1 Intervention
Patients will receive a single-pulse TMS mapping of the motor area for the following reasons to determine the motor threshold, measure concurrent EMG, and mapping of the upper extremity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
The Magstim Rapid2,
2016
N/A
~10

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,358 Previous Clinical Trials
816,811 Total Patients Enrolled
25 Trials studying Epilepsy
3,041 Patients Enrolled for Epilepsy
Anli Liu, MD, MAPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS) (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT02741193 — N/A
Epilepsy Research Study Groups: nTMS
Epilepsy Clinical Trial 2023: Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS) Highlights & Side Effects. Trial Name: NCT02741193 — N/A
Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS) (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02741193 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must be met to join this medical research study?

"This medical study is accepting 14 eligible individuals between the ages 12 and 60 with aura. In order to be considered, these patients must also adhere to additional prerequisites: age range of 12-60 years old and upcoming surgery involving subdural electrodes over the precentral gyrus."

Answered by AI

Is this study open to elderly individuals who have reached the age of 75 or more?

"For inclusion in this clinical trial, potential participants must be aged between 12 and 60 years."

Answered by AI

Are there any slots available to join this clinical experiment?

"According to clinicaltrials.gov, this research project is not presently recruiting participants; however, it was initially posted on September 10th 2016 and subsequently updated on August 26th 2022. Despite being inactive, 239 alternative trials are currently in the process of enrolling trialists."

Answered by AI
~0 spots leftby Mar 2025